Van Cleef Asset Management’s Pfizer PFE Stock Holding History

Van Cleef Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.25M	Sell	44,347 -1,200	-3%	-$31.9K	0.13%	53
2025 Q4	$1.13M	Hold	45,547	–	–	0.12%	55
2025 Q3	$1.16M	Sell	45,547 -108	-0.2%	-$2.67K	0.12%	54
2025 Q2	$1.11M	Sell	45,655 -2,008	-4%	-$46.8K	0.12%	55
2025 Q1	$1.21M	Sell	47,663 -189	-0.4%	-$4.95K	0.14%	54
2024 Q4	$1.27M	Sell	47,852 -2,508	-5%	-$68K	0.14%	57
2024 Q3	$1.46M	Sell	50,360 -29,023	-37%	-$847K	0.16%	54
2024 Q2	$2.22M	Sell	79,383 -6,603	-8%	-$182K	0.28%	45
2024 Q1	$2.39M	Sell	85,986 -2,272	-3%	-$63K	0.3%	43
2023 Q4	$2.54M	Buy	88,258 +5,613	+7%	+$170K	0.36%	40
2023 Q3	$2.74M	Sell	82,645 -1,003	-1%	-$35.5K	0.43%	37
2023 Q2	$3.07M	Sell	83,648 -378	-0.4%	-$14.7K	0.47%	35
2023 Q1	$3.43M	Sell	84,026 -314	-0.4%	-$13.6K	0.54%	28
2022 Q4	$4.32M	Sell	84,340 -136	-0.2%	-$6.52K	0.71%	29
2022 Q3	$3.7M	Sell	84,476 -2,739	-3%	-$133K	0.71%	29
2022 Q2	$4.57M	Buy	87,215 +4,426	+5%	+$226K	0.77%	29
2022 Q1	$4.29M	Buy	82,789 +3,080	+4%	+$160K	0.62%	31
2021 Q4	$4.71M	Buy	79,709 +2,044	+3%	+$101K	0.66%	31
2021 Q3	$3.34M	Sell	77,665 -1,004	-1%	-$44.5K	0.5%	33
2021 Q2	$3.08M	Sell	78,669 -390	-0.5%	-$15.2K	0.46%	36
2021 Q1	$2.86M	Sell	79,059 -319	-0.4%	-$11.3K	0.45%	36
2020 Q4	$2.92M	Sell	79,378 -4,521	-5%	-$166K	0.48%	35
2020 Q3	$2.92M	Sell	83,899 -8,441	-9%	-$296K	0.55%	32
2020 Q2	$2.87M	Sell	92,340 -16,140	-15%	-$548K	0.58%	30
2020 Q1	$3.36M	Sell	108,480 -1,672	-2%	-$57K	0.83%	27
2019 Q4	$4.09M	Sell	110,152 -705	-0.6%	-$25.1K	0.84%	28
2019 Q3	$3.78M	Sell	110,857 -413	-0.4%	-$15K	0.83%	28
2019 Q2	$4.57M	Sell	111,270 -1,503	-1%	-$59.7K	1.01%	27
2019 Q1	$4.54M	Buy	112,773 +4,235	+4%	+$170K	1.05%	25
2018 Q4	$4.5M	Sell	108,538 -1,020	-0.9%	-$42.3K	1.2%	23
2018 Q3	$4.58M	Buy	109,558 +135	+0.1%	+$5.2K	1.02%	27
2018 Q2	$3.77M	Buy	109,423 +1,262	+1%	+$43.1K	0.9%	26
2018 Q1	$3.64M	Sell	108,161 -1,480	-1%	-$50.9K	0.9%	28
2017 Q4	$3.77M	Buy	109,641 +12,241	+13%	+$417K	0.93%	28
2017 Q3	$3.3M	Buy	97,400 +1,181	+1%	+$38K	0.9%	29
2017 Q2	$3.07M	Buy	96,219 +203	+0.2%	+$6.4K	0.89%	30
2017 Q1	$3.12M	Buy	96,016 +3,090	+3%	+$97.4K	0.95%	31
2016 Q4	$2.86M	Sell	92,926 -315	-0.3%	-$9.62K	0.92%	31
2016 Q3	$3M	Sell	93,241 -3,476	-4%	-$116K	0.99%	31
2016 Q2	$3.23M	Buy	96,717 +897	+0.9%	+$28.6K	1.11%	27
2016 Q1	$2.69M	Sell	95,820 -841	-0.9%	-$24K	0.95%	32
2015 Q4	$2.96M	Sell	96,661 -394	-0.4%	-$12.4K	1.09%	31
2015 Q3	$2.89M	Buy	97,055 +1,450	+2%	+$46.5K	1.14%	30
2015 Q2	$3.04M	Sell	95,605 -562	-0.6%	-$18.3K	1.13%	30
2015 Q1	$3.17M	Sell	96,167 -2,950	-3%	-$93.8K	1.18%	30
2014 Q4	$2.93M	Buy	99,117 +35,705	+56%	+$1.02M	1.08%	29
2014 Q3	$1.78M	Sell	63,412 -50	-0.1%	-$1.4K	0.73%	34
2014 Q2	$1.79M	Buy	63,462 +7,796	+14%	+$222K	0.75%	33
2014 Q1	$1.7M	Buy	55,666 +740	+1%	+$22.1K	0.74%	33
2013 Q4	$1.6M	Buy	54,926 +1,360	+3%	+$39.6K	0.7%	32
2013 Q3	$1.46M	Buy	53,566 +2,095	+4%	+$57K	0.72%	33
2013 Q2	$1.37M	Buy	+51,471	New	+$1.42M	0.72%	34

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Van Cleef Asset Management's PFE Position: Q1 2026 in Review

Van Cleef Asset Management reduced its Pfizer (PFE) stake by 2.6% in Q1 2026, selling an estimated $31.9K and leaving 44,347 shares worth $1.25M. The position accounts for 0.13% of the portfolio, ranked #53.

Van Cleef Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.71M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Van Cleef Asset Management held 44,347 shares of Pfizer worth $1.25M as of Q1 2026.
Van Cleef Asset Management sold 1,200 Pfizer shares in Q1 2026, an estimated $31.9K.
Pfizer made up 0.13% of Van Cleef Asset Management's portfolio in Q1 2026, its #53 holding.
Van Cleef Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Van Cleef Asset Management's Pfizer position peaked at $4.71M in Q4 2021.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Van Cleef Asset Management's 13F filing for Q1 2026, filed 1 May 2026.